Publications
2 shownCRISPR-engineered T cells in patients with refractory cancer
CRISPR takes first steps in humans CRISPR-Cas9 is a revolutionary gene-editing technology that offers the potential to treat diseases such as cancer, but the effects of CRISPR i...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,743
- Institution
- Stanford University
External Links
Identifiers
- ORCID
- 0000-0003-0537-1540
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.